Michael R. Verneris
Department of Pediatrics
University of Minnesota Medical School
Minneapolis
MN 55455
USA
Name/email consistency: high
- Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Verneris, M.R., Brunstein, C.G., Barker, J., MacMillan, M.L., DeFor, T., McKenna, D.H., Burke, M.J., Blazar, B.R., Miller, J.S., McGlave, P.B., Weisdorf, D.J., Wagner, J.E. Blood (2009)
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Verneris, M.R., Miller, J.S. Br. J. Haematol. (2009)
- Recent developments in cell-based immune therapy for neuroblastoma. Verneris, M.R., Wagner, J.E. J. Neuroimmune. Pharmacol (2007)
- Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. Verneris, M.R., Arshi, A., Edinger, M., Kornacker, M., Natkunam, Y., Karami, M., Cao, Y.A., Marina, N., Contag, C.H., Negrin, R.S. Clin. Cancer Res. (2005)
- Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Verneris, M.R., Karami, M., Baker, J., Jayaswal, A., Negrin, R.S. Blood (2004)